Pertactin and filamentous hemagglutinin (FHA), proteins present on the surface of the gram-negative organism Bordetella pertussis, have been shown to contain the putative cell-binding sequence arginine-glycineaspartic acid (RGD) and to promote eukaryotic cell attachment. The attachment of epithelial cells to purified pertactin and the entry of B. pertussis into human HeLa cells are both inhibited by an RGD-containing peptide derived from the pertactin sequence. In contrast, an RGD-containing peptide derived from the FHA sequence has no effect on either the attachment of epithelial cells to purified FHA or the entry of B. pertussis into HeLa cells. Staphylococcus aureus organisms coated with pertactin or FHA, purified from B. pertussis, enter HeLa cells more efficiently than S. aureus cells coated with bovine serum albumin. The pertactin-enhanced entry of S. aureus is inhibited by 75% in the presence of the RGD peptide from pertactin, whereas the RGD peptide derived from FHA has no effect on the increased entry promoted by the pertactin-coated or by the FHA-coated S. aureus. These results indicate that the active uptake of B. pertussis by certain mammalian cells may be mediated by the interaction of the RGD site found in pertactin with eukaryotic cell surface receptors. 
Bordetella pertussis expresses virulence-associated attachment factors including filamentous hemagglutinin (FHA) (2, 23, 24) and pertactin (2, 15) as well as a number of toxins such as pertussis toxin and adenylate cyclase toxin which contribute to an infectious process resulting in the human respiratory illness whooping cough (25) . Although the mechanism of B. pertussis pathogenesis is not well understood, adherence to the host cell is most likely one of the first steps in infection. It is not known whether B. pertussis can invade and survive within epithelial cells during the natural course of infection. Recently, it has been shown that virulent B. pertussis as well as Bordetella parapertussis can enter human epithelial cells in vitro through a phagocytic, microfilament-dependent process (8, 9, 13) , an event that could further complicate our understanding of the mechanism(s) of Bordetella pathogenesis. Avirulent strains cannot attach to or enter mammalian cells (8, 13, 24) , suggesting that bacterial adherence and penetration are mediated by proteins which are regulated by the virulence gene operon (vir or bvg) of B. pertussis (1, 21) . It has not yet been established which of these vir-regulated proteins are involved in each of these processes. Some B. pertussis Tn5 or Tn5 lac insertion mutants, which do not express either FHA or pertussis toxin, are not effectively internalized by HeLa cells (8) ; however, certain other pertussis toxin-negative mutants or FHA-negative mutants (8, 13) have been shown to effectively invade HeLa cells.
Molecular analyses of FHA (7, 17) and pertactin (5) have shown that both contain the amino acid triplet arginineglycine-aspartic acid (RGD), an amino acid sequence which functions as a cell-binding site in a number of mammalian proteins (20) . We have previously shown that the RGD * Corresponding author.
sequence of pertactin is involved in the adherence of mammalian cells to the purified pertactin protein (15) . In this study, we used synthetic RGD-containing peptides, corresponding to pertactin or FHA sequences, to investigate whether interactions of B. pertussis with mammalian cells may be mediated through this potential cell-binding site. (Fig. 1B) RGE) had a significant effect on CHO cell attachment to either pertactin or Fl-A (Fig. 1) .
MATERIALS AND METHODS

Materials
Recently, we have shown that B. pertussis can invade and survive within HeLa cells in culture (9) . Electron microscopic examination of this interaction suggests an active phagocytic uptake of the bacteria by the HeLa cells (Fig. 2) .
Immunogold visualization of pertactin (large particles) and FlHA (small particles) on the surface of the bacteria shows that both molecules are distributed over the surface of the bacteria. The MAbs seem to preferentially bind the distal hemisphere of the bacteria, which suggests that pertactin (Fig. 3) . This MAb is directed against an amino-terminal epitope on pertactin which encompasses the RGD sequence as shown by epitope mapping with fusion proteins constructed from the pertactin gene (6) . Other MAbs directed against the carboxy-terminal portion of pertactin have been shown to have no effect on invasion (8 10 ,ug/ml were incubated with HeLa cell monolayers for 1 h at 37°C. Bacteria were then added, and the invasion assay was performed as previously described (8) . Only the RGD-containing peptide corresponding to the pertactin sequence, PRN-RGD, significantly inhibited the entry of B. pertussis into HeLa cells (Fig. 4) (Fig. 6) . To determine whether the RGD site on pertactin and FHA has a role in these enhanced bacterium-epithelial cell interactions, we also investigated the effect of the specific RGD-containing peptides on the S. aureus entry assay (Fig. 6) FHA (X3C) . The organisms were washed once and added to cell monolayers to assess invasiveness as described in an earlier publication (8) . The bars represent the percent mean + standard deviation of gentamicinresistant CFU recovered from five independent experiments, except for MAb F6E5, for which n = 3. Inhibition by MAb F6E5 was statistically significant compared with the control (P < 0.0005), using the two-factor analysis of variance. entry of virulent B. pertussis organisms into these human epithelial cells. Entry of the gram-positive organism S. aureus, which does not have pertactin on its surface, into HeLa cells can be increased more than fourfold by coating the surface of the bacteria with purified pertactin. The pertactin-enhanced entry of S. aureus into HeLa cells is also blocked efficiently and specifically (about 75% inhibition) by the pertactin-derived RGD peptide. Electron microscopy indicates that pertactin is localized around the surface of the bacteria, a prerequisite for invasin molecules which may function as an adhesin promoting B. pertussis attachment to mammalian cells (23, 24) . As shown here, mammalian cells will adhere to purified FHA, and the ability of S. aureus to enter HeLa cells is increased by coating these organisms with FHA.
Interestingly, our studies have demonstrated differences in the mechanisms by which FHA and pertactin promote bacterial adhesion. Although the epithelial cell lines studied here attached well to FHA, the RGD peptide homologous to the FHA sequence had no effect on epithelial cell attachment to purified FHA or to pertactin. Likewise, this peptide had no effect on entry of B. pertussis into HeLa or CHO cells. The MAb X3C directed against FHA showed limited effect on invasion of B. pertussis into HeLa cells, although it can effectively inhibit attachment of the bacterium to mammalian cell monolayers (14) . These observations suggest that the interaction of epithelial cells with FHA is not mediated through the RGD site on this bacterial adhesin. FHA has been shown, however, to interact with the CR3 integrin receptor found on macrophages (18) , and the results presented here do not rule out a contribution of the RGD region of FHA in interactions of B. pertussis with other cell types. Note that the amino acids surrounding the RGD triplet found in pertactin and FHA are different and that sequences adjacent to RGD are believed to confer receptor specificity to proteins that attach to cells via an RGD-mediated process (20) . The RGD region in FHA may specifically interact with CR3, an integrin found only on leukocytes, while, as the results presented here suggest, the RGD domain in pertactin may recognize integrins expressed by epithelial cells.
Our observations suggest that FHA is using other cellbinding sites to interact with different eukaryotic cells. Recently, a potential lectinlike site on FHA has been identified by sequence homology (7), and there is evidence that certain sugars can inhibit the attachment of B. pertussis to mammalian cells (3, 14, 22) . It is therefore likely that FHA can recognize carbohydrate receptors on the surface of certain host cells and mediate bacterial attachment through a lectinlike interaction.
Studies with various B. pertussis mutants have also provided information about the adhesive and invasive properties of FHA and pertactin. Roberts et al. (19) have demonstrated that a B. pertussis Tohama I-derived mutant, which does not express FHA, is less efficient than the parent strain in invasion of HEp-2 cells. Another mutant, deficient in the expression of pertactin, does not show a significantly decreased internalization into these cells. They have also observed, however, that a mutant lacking both pertactin and FHA shows a further decrease in internalization, approaching the low levels seen with avirulent B. pertussis strains. There is also evidence showing that mutants derived from different B. pertussis strains (W28), deficient in pertactin, interact with CHO and HeLa cells less efficiently than their parent strain (15) . We have also noticed that mutants lacking both pertactin and FHA attach to epithelial cells at a much lower level than mutants lacking either pertactin or FHA alone (2). These observations provide evidence that the two surface proteins may act in concert to promote efficient attachment of the pathogen to host cells, as has also been proposed for FHA and pertussis toxin double mutants (18) .
It is always difficult to determine whether the measurement of entry of the bacterial ligand into host cells simply reflects the ability of these microorganisms to avidly interact with the surface of the host cell. In fact, the RGD peptides used for these studies do not effectively and/or reproducibly inhibit the total attachment (adhered and internalized) of B.
pertussis to epithelial cell monolayers (data not shown). This is most likely due to the presence of multiple adhesins on this pathogen which mediate bacterium-mammalian cell interactions via different pathways. We believe, however, that a specific effect of the RGD peptide homologous to the sequence of pertactin on entry of B. pertussis into epithelial cells has been shown in this report. At this time, a more complete molecular analysis of pertactin-mediated bacterial entry is required before pertactin can be defined as an invasin protein. The possibility that specific integrins actively promote the entry of B. pertussis into human cells after binding pertactin also warrants further study.
